About the 14th World ADC San Diego
The World’s Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Thank you to our speakers, sponsors, and delegates who joined us in San Diego for the summit! If you are interested in the 2024 event, please get in touch at email@example.com
What you missed!
As the ADC wave rises to new heights, the 14th World ADC San Diego returns as a much-needed platform for novel scientific breakthroughs and valuable insights to propel your ADC pipeline forward.
With dedicated sessions on next-generation payloads focusing on novel mechanisms of action, preclinical biology, translational studies, overcoming off-target toxicities or understanding complex ADC manufacturing processes - there truly is something for everyone.
No matter what stage of development you're focusing on, this is your global one-stop shop for antibody-drug conjugates from early discovery to late-phase manufacturing including:
More than Just a Meeting
It has been fantastic to see our community grow over the years and continue to advance the development of ADCs. In addition to the unrivalled scientific content in the form of presentations, panels and roundtable discussions, there was a variety of extra experiences that you missed this year including:
1000+ Attendees Including...
A Sneak Peek of Your 4-day World ADC San Diego Experience
Seminar Days –
Introduction to ADCs
Aimed at those new to the field, enjoy this one-day deep dive into the fundamental principles of ADC design and early development.
NEW - 1st Next-Generation Payloads Conjugates Day
This seminar day will showcase structures and early data from immunomodulatory, protein degrader, oligonucleotide, and radio conjugate ADCs.
4th Toxicity Day
Join toxicology experts to help explain, understand, and create strategies to mitigate toxicities.
2nd CQA & Bioanalytical Day
Learn about the latest technological developments to improve the characterization of your ADC post-administration to better inform clinical strategy and design.
7th ADCs in Combination Day
Gain insight into combination rationale, benchmark best practices on when and how to combine, explore beyond ADC and IO combinations, and leave with the toolkit to successfully implement your ADC into a combination trial.
5th CMC Day
Benchmarking regulatory expectations, optimizing relationships with CDMOs, and understanding best practices in scale-up are a few of the key themes of this day to enable you to confidently develop your CMC operations to be ready for commercialization.
NEW - 1st Translational Biomarkers & Patient Selection Day
With 49% of ADCs currently progressing through preclinical, pivotal studies, aiming to file an IND and reach the clinic as soon as possible, identifying valuable translational biomarkers and optimizing patient selection has never been more important. Join BioAtla, Takeda, Eisai, AbbVie and more as they overcome challenges in maximizing preclinical models, utilizing proteomics in biomarker strategies, exploring personalized therapeutics and more.
Scientific Program Days –
With 6 defined streams allowing conversation between like-minded individuals, we will provide comprehensive coverage of the end-to-end development to make this your global one-stop shop for all things ADC!
To ensure we are providing your entire team with the insights that they need to advance their work, we break our agenda into six tracks:
- Discovery Chemistry
- Cellular Biology
- Clinical Lessons
- Process & Analytical Development
- Manufacturing & Supply Chain
Throughout the day, there will be breaks with Structured Networking opportunities to help you build those all-important connections and collaborations that have propelled the ADC field forward.
Finish Day One by joining our popular Scientific Poster Session, while joining us at the end of Day Two for the renowned 10th Annual World ADC Awards.
Workshop Day –
Finish your World ADC experience by getting involved in our intimate discussion working groups to delve into more niche topics, with many options for each member of your entire team.
Returning with new content, new structure, and new leaders, join 2 of the 12 workshops spanning early discovery, through translational and clinical development, and finally on to process development and manufacturing.
Take a pick of the workshops including:
- Using Computational Approaches for Early-Stage Design & Late-Stage Development of Antibody Drug Conjugates
- Exploring the Effects of Linker Choice on Your Toxin
- Discussing Analytical Strategies, Technologies & Methods for Complex Molecules
- The Beauty and the Beast: Match Making of Tumor Targets to Antitumor Payloads
- Deep-dive Analysis of Conjugation Technology Options